Stay Updated
Press Releases
Patients For Affordable Drugs Statement on Governor Brown Signing SB 17
LA PUENTE, CA — The following statement was issued by Victoria Stuessel, a Multiple Sclerosis patient, mother, and La Puente, CA resident seeking relief from skyrocketing drug prices. Victoria is a volunteer Patient Advocate in the Patients For Affordable Drugs community. “Patients like me can breathe a sigh of relief today. For years, I’ve struggled […]
Press Releases
WASHINGTON, DC—Patients For Affordable Drugs applauded a request led by U.S. Senator Maggie Hassan calling on Congress to investigate Allergan’s outrageous legal maneuver to transfer the patent of a blockbuster drug to the St. Regis Mohawk Tribe and maintain its monopoly. The anti-competitive and unprecedented legal dodge by the international drug corporation thwarts the will […]
Press Releases
Statement from Patients For Affordable Drugs on Novartis' Drug Price
WASHINGTON, DC — The following statement was issued by David Mitchell, Founder and President of Patients For Affordable Drugs, regarding Novartis’ decision to price its CAR-T drug, Kymriah, at $475,000 per treatment. “As a cancer patient, the potential of CAR-T is exciting and I applaud FDA’s approval. It means hope for hundreds of children and […]
Press Releases
Patients For Affordable Drugs Launches Campaign Demanding Fair Pricing of New Novartis Cancer Drug
WASHINGTON, DC – Patients for Affordable Drugs launched a national campaign today to demand pharmaceutical giant Novartis price its new cancer drug fairly and in accordance with the fact that American taxpayers invested over $200 million to help discover the drug. In a letter to the CEO of Novartis, Patients For Affordable Drugs requested a […]
Press Releases
Patients For Affordable Drugs Urges FDA to Stop Abuses by Drug Corporations
WASHINGTON, DC – Patients For Affordable Drugs President and founder David Mitchell will urge the Food and Drug Administration (FDA) to take action to boost generic competition and help fix out-of-control drug prices. At a public meeting today, Mitchell will share his story about how the out-of-pocket cost for Revlimid, a cancer drug he took […]
Press Releases
Cancer Patient Sues Big Pharma for Illegal Price Gouging
WASHINGTON, DC – A patient with incurable blood cancer filed a class action lawsuit against Celgene Corporation for abusing consumer safety rules and maintaining a monopoly over its high-cost cancer drugs. The suit alleges Celgene illegally blocked generic development for its highly effective drugs Thalomid and Revlimid—the latter of which costs more than $12,000 for […]
Press Releases
Patients For Affordable Drugs Goes Inside the Belly of the Beast
June 8, 2017 Contact: [email protected] BOSTON, MA – Patients For Affordable Drugs is taking the fight for lower drug prices inside one of America’s biggest drug corporations. Today, Juliana Keeping, the mother of a cystic fibrosis child is headed to Vertex Pharmaceuticals’ annual shareholder meeting to confront company executives about their price gouging tactics and […]
Press Releases
Patients For Affordable Drugs Launches Petition to Lower Drug Prices
April 11, 2017 Contact: [email protected] WASHINGTON, D.C. – Today, Patients For Affordable Drugs launched a nationwide petition urging lawmakers to allow Medicare to negotiate lower drug prices on behalf of patients and taxpayers. The petition was launched by David Mitchell, a patient with incurable blood cancer whose drugs cost $20,000 per bi-weekly treatment. The petition […]